Fox Chase Cancer Center News

PHILADELPHIA (September 27, 2019) – These results underscore the ability of a higher-volume facility to provide patients with more experience, expertise, and access to resources.

PHILADELPHIA (September 23, 2019) – Edna Cukierman, PhD, was awarded the grant from the National Institutes of Health/National Cancer Institute to begin research on better understanding the deterioration of collagen integrity via cellular aging and its role in melanoma metastasis.

PHILADELPHIA (September 23, 2019) – Of the 112 patients examined, 14 percent developed at least one cranial neuropathy. The median time was more than seven years, with some patients developing it more than 10 years later.

PHILADELPHIA (September 20, 2019) – Many of the most common treatment modalities for localized non-melanoma skin cancers resulted in similar cosmetic outcome and local control one year after treatment, according to a new study from researchers at Fox Chase Cancer Center.

CHICAGO (September 15, 2019) – New research from Fox Chase Cancer Center may help guide men with prostate cancer in selecting the appropriate type of short course radiation therapy to treat their disease.

CHICAGO (September 15, 2019) – Patients with esophageal cancer who experienced severe lymphopenia after undergoing chemoradiation were more likely to have their disease recur and were at greater risk for death, according to a new study from researchers at Fox Chase Cancer Center.

PHILADELPHIA (September 13, 2019) – Fox Chase Cancer Center hired Michael Jay Styler, MD, for the Department of Hematology/Oncology as an associate professor in the Bone Marrow Transplant Program.

PHILADELPHIA (September 11, 2019) – Denise Connolly, PhD, an associate professor in the Molecular Therapeutics Program, has won the Sandy Rollman Ovarian Cancer Foundation’s Teal Trailblazer Award. She is currently researching high-grade serous carcinoma to understand why not all ovarian cancer arises in the ovary.